On this episode we welcome Dr. Evagelou, the co-founder and CSO of OpenDNA.

OpenDNA has developed a cloud-based genomic precision medicine platform bound to change our lives!

By using AI to analyze each patient's specific genetic and clinical data, this groundbreaking platform can predict if a person is at risk of developing cardiometabolic syndrome, enabling physicians to offer effective Personalized treatments to patients.

Future Goals?

To apply the technology to other complex polygenic disease states such as cancer, osteoporosis and autoimmune diseases.